This four day live remote program is ideal for research and translational biology scientists who are looking for a balanced theoretical and introduction to isolation, quantitation, analysis and engineering of [….]
EVerZom, a biopharmaceutical company specialized in the bioproduction of exosomes, announced today that it has raised €1.1 million in funding from institutional and private investors to develop its exosome bioproduction platform.
